Select Medical Holdings Corporation (NYSE:SEM) shares fell to a low of $39.14 before closing at $39.77. Intraday shares traded counted 1.67 million, which was -114.87% lower than its 30-day average trading volume of 776.63K. SEM’s previous close was $38.86 while the outstanding shares total 130.33M. The firm has a beta of 1.41, a 12-month trailing P/E ratio of 16.93, and a growth ratio of 0.91. The stock’s Relative Strength Index (RSI) is 67.51, with weekly volatility at 2.84% and ATR at 1.16. The SEM stock’s 52-week price range has touched low of $13.51 and a $39.76 high. The stock traded higher over the last trading session, gaining 2.34% on 05/24/21.
Investors have identified the Medical Care Facilities company Select Medical Holdings Corporation as an interesting stock but before investments are made there, an in-depth look at its trading activities will have to be conducted. The share is trading with a market value of around $5.28 billion, the company now has both obstacles and catalysts that affect them and they came from their mode of operations. With the company affected by events currently, it is a perfect time to analyze the numbers behind the firm in order to come up with a rather realistic picture of what this stock is.
Select Medical Holdings Corporation (SEM) Fundamentals that are to be considered.
When analyzing a stock, the first fundamental thing to take into account is the balance sheet. How healthy the balance sheet of a company is will determine if the company will be able to carry out all its financial and non-financial obligations and also keep the faith of its investors. For SEM, the company has in raw cash 750.27 million on their books with 15.43 million currently as liabilities. How the trend is over time is what investors should be concerned about. The company has a healthy balance sheet as their debt profile has been on an incline. In terms of their assets, the company currently has 1.84 billion total, with 1.54 billion as their total liabilities.
SEM were able to record 200.17 million as free cash flow during the 08/05/2021 quarter of the year, this saw their quarterly net cash flow reduce by 173.21 million. In cash movements, the company had a total of 239.89 million as operating cash flow.
Potential earnings growth for Select Medical Holdings Corporation (SEM)
In order to determine the future investment potential for this stock, we will have to analyze key trends that affect it. During the 08/05/2021 quarter of the year, Select Medical Holdings Corporation recorded a total of 1.55 billion in revenue. This figure implies that they witnessed a quarterly year/year change in their earnings with 8.52% coming in sequential stages and their sales for the 08/05/2021 quarter increasing by 5.56%.
What matters though is how it ends. When the core data for the company is broken down, then the stock sounds interesting. The company spent 1.29 billion trying to sell their products during the last quarter, with the result yielding a gross income of 253.01 million. This allows shareholders to hold on to 130.33M with the recently reported earning now reading 1.05 cents per share. This is a figure that compared to analyst’s prediction for their 08/05/2021 (0.82 cents a share).
Having a look at the company’s valuation, the company is expected to record 2.86 total earnings per share during the next fiscal year. It is very important though to remember that the importance of trend far outweighs that of outlook. This analysis has been great and getting further updates on SEM sounds very interesting.
Is the stock of SEM attractive?
In related news, Vice President, Compliance, Breighner Robert G. JR sold 5,040 shares of the company’s stock in a transaction that recorded on May 10. The sale was performed at an average price of 37.07, for a total value of 186,833. As the sale deal closes, the Director, Ely James S. III now sold 5,644 shares of the company’s stock, valued at 197,653. Also, Director, Ely James S. III sold 4,656 shares of the company’s stock in a deal that was recorded on Mar 12. The shares were price at an average price of 35.01 per share, with a total market value of 163,007. Following this completion of acquisition, the Director, Ely James S. III now holds 9,700 shares of the company’s stock, valued at 339,694. In the last 6 months, insiders have changed their ownership in shares of company stock by 4.90%.
4 out of 5 analysts covering the stock have rated it a Buy, while 1 have maintained a Hold recommendation on Select Medical Holdings Corporation. 0 analysts has assigned a Sell rating on the SEM stock. The 12-month mean consensus price target for the company’s shares has been set at $43.60.